(Q48900576)

English

Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies

scientific article published on September 1, 1991

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

title

Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

author name string

M. E. Marshall

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1768368

retrieved

19 November 2022

K. Butler

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1768368

retrieved

19 November 2022

A. Fried

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1768368

retrieved

19 November 2022

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed ID

1768368

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1768368

retrieved

19 November 2022

publication date

1 September 1991

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

volume

3

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

page(s)

170-178

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 September 2019

Identifiers

PubMed ID

1768368

1 reference

stated in

Europe PubMed Central

PubMed ID

1768368

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1768368%20AND%20SRC:MED&resulttype=core&format=json

(Q48900576)

Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)